| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | neuron projection development | EFHC2 POSTN RIPOR2 CIB1 NF1 HMCN2 SNAP91 FEZ2 MTOR SYNE1 SIPA1L1 VASH2 DHFR2 APC AFDN SPAG9 RERE ADGRV1 FXN HOXA2 | 1.92e-07 | 1285 | 85 | 20 | GO:0031175 |
| GeneOntologyBiologicalProcess | neuron development | EFHC2 POSTN RIPOR2 CIB1 NF1 HMCN2 SNAP91 FEZ2 MTOR SYNE1 SIPA1L1 VASH2 DHFR2 APC AFDN SPAG9 RERE ADGRV1 FXN HOXA2 | 1.49e-06 | 1463 | 85 | 20 | GO:0048666 |
| GeneOntologyBiologicalProcess | regulation of organelle assembly | 2.03e-05 | 280 | 85 | 8 | GO:1902115 | |
| GeneOntologyBiologicalProcess | vesicle budding from membrane | 3.72e-05 | 91 | 85 | 5 | GO:0006900 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | POSTN HMCN2 SNAP91 FEZ2 SYNE1 SIPA1L1 APC AFDN SPAG9 RERE FXN HOXA2 | 1.07e-04 | 802 | 85 | 12 | GO:0048812 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | POSTN HMCN2 SNAP91 FEZ2 SYNE1 SIPA1L1 APC AFDN SPAG9 RERE FXN HOXA2 | 1.30e-04 | 819 | 85 | 12 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | POSTN HMCN2 SNAP91 FEZ2 SYNE1 SIPA1L1 APC AFDN SPAG9 RERE FXN HOXA2 | 1.41e-04 | 826 | 85 | 12 | GO:0048858 |
| GeneOntologyBiologicalProcess | regulation of mini excitatory postsynaptic potential | 1.66e-04 | 5 | 85 | 2 | GO:0061884 | |
| GeneOntologyBiologicalProcess | mini excitatory postsynaptic potential | 1.66e-04 | 5 | 85 | 2 | GO:0098816 | |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | EFHC2 RIPOR2 CIB1 NF1 SNAP91 MTOR SYNE1 SIPA1L1 APC AFDN FXN CNTROB | 1.76e-04 | 846 | 85 | 12 | GO:0120035 |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | EFHC2 RIPOR2 CIB1 NF1 SNAP91 MTOR SYNE1 SIPA1L1 APC AFDN FXN CNTROB | 2.11e-04 | 863 | 85 | 12 | GO:0031344 |
| GeneOntologyBiologicalProcess | organelle assembly | LRFN1 RIPOR2 FEZ2 MTOR SYNE1 SIPA1L1 MTERF3 RAB7B POGZ ATM ARMC2 CCDC38 CNTROB DDX28 | 2.16e-04 | 1138 | 85 | 14 | GO:0070925 |
| HumanPheno | Cafe-au-lait spot | 1.34e-05 | 137 | 31 | 7 | HP:0000957 | |
| HumanPheno | Multiple cafe-au-lait spots | 3.53e-05 | 64 | 31 | 5 | HP:0007565 | |
| HumanPheno | Abnormal glial cell morphology | 9.99e-05 | 187 | 31 | 7 | HP:0100705 | |
| HumanPheno | Square-wave jerks | 1.07e-04 | 3 | 31 | 2 | HP:0025402 | |
| HumanPheno | Saccadic intrusion | 1.07e-04 | 3 | 31 | 2 | HP:0032114 | |
| HumanPheno | macules | 1.23e-04 | 262 | 31 | 8 | HP:0200031 | |
| Domain | ARM-type_fold | AP4E1 NCAPD3 RIPOR2 NF1 MTOR VEPH1 INTS1 APC ATM ARMC2 VIRMA | 3.86e-07 | 339 | 85 | 11 | IPR016024 |
| Domain | - | 6.86e-05 | 222 | 85 | 7 | 1.25.10.10 | |
| Domain | FATC | 2.03e-04 | 5 | 85 | 2 | PF02260 | |
| Domain | ARM-like | 2.31e-04 | 270 | 85 | 7 | IPR011989 | |
| Domain | FAT | 3.03e-04 | 6 | 85 | 2 | PS51189 | |
| Domain | FATC | 3.03e-04 | 6 | 85 | 2 | PS51190 | |
| Domain | FAT | 3.03e-04 | 6 | 85 | 2 | PF02259 | |
| Domain | PIK-rel_kinase_FAT | 3.03e-04 | 6 | 85 | 2 | IPR003151 | |
| Domain | FATC_dom | 3.03e-04 | 6 | 85 | 2 | IPR003152 | |
| Domain | PIK_FAT | 3.03e-04 | 6 | 85 | 2 | IPR014009 | |
| Domain | FATC | 3.03e-04 | 6 | 85 | 2 | SM01343 | |
| Domain | Calx_beta | 7.22e-04 | 9 | 85 | 2 | IPR003644 | |
| Domain | Calx-beta | 7.22e-04 | 9 | 85 | 2 | PF03160 | |
| Domain | Helicase_C | 1.44e-03 | 107 | 85 | 4 | PF00271 | |
| Domain | HELICc | 1.44e-03 | 107 | 85 | 4 | SM00490 | |
| Domain | Helicase_C | 1.49e-03 | 108 | 85 | 4 | IPR001650 | |
| Domain | HELICASE_CTER | 1.55e-03 | 109 | 85 | 4 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 1.55e-03 | 109 | 85 | 4 | PS51192 | |
| Domain | DEXDc | 1.55e-03 | 109 | 85 | 4 | SM00487 | |
| Domain | Helicase_ATP-bd | 1.60e-03 | 110 | 85 | 4 | IPR014001 | |
| Domain | PI3/4_kinase_CS | 2.07e-03 | 15 | 85 | 2 | IPR018936 | |
| Domain | - | 2.36e-03 | 16 | 85 | 2 | 1.10.1070.11 | |
| Domain | PI3Kc | 2.36e-03 | 16 | 85 | 2 | SM00146 | |
| Domain | PI3/4_kinase_cat_dom | 2.99e-03 | 18 | 85 | 2 | IPR000403 | |
| Domain | PI3_PI4_kinase | 2.99e-03 | 18 | 85 | 2 | PF00454 | |
| Domain | PI3_4_KINASE_3 | 2.99e-03 | 18 | 85 | 2 | PS50290 | |
| Domain | PI3_4_KINASE_1 | 2.99e-03 | 18 | 85 | 2 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 2.99e-03 | 18 | 85 | 2 | PS00916 | |
| Domain | CH | 3.24e-03 | 65 | 85 | 3 | SM00033 | |
| Domain | CH | 4.00e-03 | 70 | 85 | 3 | PF00307 | |
| Domain | - | 4.16e-03 | 71 | 85 | 3 | 1.10.418.10 | |
| Domain | DEAD/DEAH_box_helicase_dom | 4.50e-03 | 73 | 85 | 3 | IPR011545 | |
| Domain | CH | 4.50e-03 | 73 | 85 | 3 | PS50021 | |
| Domain | DEAD | 4.50e-03 | 73 | 85 | 3 | PF00270 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | NCAPD3 EXO5 NF1 SIPA1L1 AFDN MICAL3 SPAG9 POGZ ATM PROSER2 RERE VIRMA | 5.23e-07 | 774 | 87 | 12 | 15302935 |
| Pubmed | A Network of Conserved Synthetic Lethal Interactions for Exploration of Precision Cancer Therapy. | 6.40e-07 | 65 | 87 | 5 | 27453043 | |
| Pubmed | MIA3 LRFN1 NF1 SNAP91 MTOR OSBPL3 N4BP2 SYNE1 SIPA1L1 APC AFDN SEC31A VIRMA | 8.00e-07 | 963 | 87 | 13 | 28671696 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | PDIA4 NCAPD3 NF1 PITRM1 MTOR SYNE1 ANP32A AFDN POGZ SEC31A ATM LTF CMYA5 CCDC38 TFG | 2.35e-06 | 1425 | 87 | 15 | 30948266 |
| Pubmed | 5.55e-06 | 653 | 87 | 10 | 22586326 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 15542845 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 26191215 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 31968254 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 22173835 | ||
| Pubmed | Periostin responds to mechanical stress and tension by activating the MTOR signaling pathway. | 6.19e-06 | 2 | 87 | 2 | 24349533 | |
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 28665915 | ||
| Pubmed | NF1 patient missense variants predict a role for ATM in modifying neurofibroma initiation. | 6.19e-06 | 2 | 87 | 2 | 31664505 | |
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 24092877 | ||
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 21748792 | ||
| Pubmed | Association of ATM and BMI-1 genetic variation with breast cancer risk in Han Chinese. | 6.19e-06 | 2 | 87 | 2 | 29691986 | |
| Pubmed | 6.19e-06 | 2 | 87 | 2 | 17700532 | ||
| Pubmed | Vasohibin-2 modulates tumor onset in the gastrointestinal tract by normalizing tumor angiogenesis. | 6.19e-06 | 2 | 87 | 2 | 24885408 | |
| Pubmed | Identification of a novel protein kinase mediating Akt survival signaling to the ATM protein. | 6.19e-06 | 2 | 87 | 2 | 12409306 | |
| Pubmed | CTDP1 regulates breast cancer survival and DNA repair through BRCT-specific interactions with FANCI. | 6.60e-06 | 104 | 87 | 5 | 31240132 | |
| Pubmed | 8.57e-06 | 407 | 87 | 8 | 12693553 | ||
| Pubmed | Autism risk gene POGZ promotes chromatin accessibility and expression of clustered synaptic genes. | 1.00e-05 | 17 | 87 | 3 | 34879283 | |
| Pubmed | Colorectal Tumors Require NUAK1 for Protection from Oxidative Stress. | 1.85e-05 | 3 | 87 | 2 | 29500295 | |
| Pubmed | Arlm1 is a male-specific modifier of astrocytoma resistance on mouse Chr 12. | 1.85e-05 | 3 | 87 | 2 | 22234937 | |
| Pubmed | USP22 exerts tumor-suppressive functions in colorectal cancer by decreasing mTOR activity. | 1.85e-05 | 3 | 87 | 2 | 31527800 | |
| Pubmed | 1.85e-05 | 3 | 87 | 2 | 19725049 | ||
| Pubmed | 1.85e-05 | 3 | 87 | 2 | 37211171 | ||
| Pubmed | BMI1 attenuates etoposide-induced G2/M checkpoints via reducing ATM activation. | 1.85e-05 | 3 | 87 | 2 | 25088203 | |
| Pubmed | 1.85e-05 | 3 | 87 | 2 | 22362778 | ||
| Pubmed | 1.85e-05 | 3 | 87 | 2 | 11181458 | ||
| Pubmed | 1.85e-05 | 3 | 87 | 2 | 21641396 | ||
| Pubmed | ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS. | 1.85e-05 | 3 | 87 | 2 | 20160076 | |
| Pubmed | NCAPD3 SPCS3 IMPDH1 ATAD5 SYNE1 SIPA1L1 INTS1 LRCH4 HLTF APC AFDN VIRMA AHDC1 DDX28 | 2.01e-05 | 1497 | 87 | 14 | 31527615 | |
| Pubmed | mTOR drives its own activation via SCF(βTrCP)-dependent degradation of the mTOR inhibitor DEPTOR. | 2.58e-05 | 23 | 87 | 3 | 22017875 | |
| Pubmed | Combinatorial CRISPR-Cas9 screens for de novo mapping of genetic interactions. | 3.12e-05 | 71 | 87 | 4 | 28319113 | |
| Pubmed | Functional coupling of presequence processing and degradation in human mitochondria. | 3.70e-05 | 4 | 87 | 2 | 32491259 | |
| Pubmed | 3.70e-05 | 4 | 87 | 2 | 22452792 | ||
| Pubmed | 3.70e-05 | 4 | 87 | 2 | 21305053 | ||
| Pubmed | Involvement of the telomeric protein Pin2/TRF1 in the regulation of the mitotic spindle. | 3.70e-05 | 4 | 87 | 2 | 11943150 | |
| Pubmed | MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1. | 3.70e-05 | 4 | 87 | 2 | 24509877 | |
| Pubmed | p53 and NF 1 loss plays distinct but complementary roles in glioma initiation and progression. | 3.70e-05 | 4 | 87 | 2 | 29392777 | |
| Pubmed | ANP32A regulates ATM expression and prevents oxidative stress in cartilage, brain, and bone. | 3.70e-05 | 4 | 87 | 2 | 30209244 | |
| Pubmed | mTORC1 signaling under hypoxic conditions is controlled by ATM-dependent phosphorylation of HIF-1α. | 3.70e-05 | 4 | 87 | 2 | 21095582 | |
| Pubmed | 3.70e-05 | 4 | 87 | 2 | 21062985 | ||
| Pubmed | Tumor microenvironment confers mTOR inhibitor resistance in invasive intestinal adenocarcinoma. | 3.70e-05 | 4 | 87 | 2 | 28759045 | |
| Pubmed | The SALM/Lrfn family of leucine-rich repeat-containing cell adhesion molecules. | 3.70e-05 | 4 | 87 | 2 | 21736948 | |
| Pubmed | 3.70e-05 | 4 | 87 | 2 | 25082813 | ||
| Pubmed | Bmi1 is required for tumorigenesis in a mouse model of intestinal cancer. | 3.70e-05 | 4 | 87 | 2 | 23955081 | |
| Pubmed | 5-HT(6) receptor recruitment of mTOR as a mechanism for perturbed cognition in schizophrenia. | 4.23e-05 | 27 | 87 | 3 | 23027611 | |
| Pubmed | 4.26e-05 | 153 | 87 | 5 | 10718198 | ||
| Pubmed | 6.16e-05 | 5 | 87 | 2 | 20668194 | ||
| Pubmed | Multiple cellular proteins interact with LEDGF/p75 through a conserved unstructured consensus motif. | 6.16e-05 | 5 | 87 | 2 | 26245978 | |
| Pubmed | 6.16e-05 | 5 | 87 | 2 | 34496236 | ||
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | PDIA4 NBAS SPCS3 MIA3 PITRM1 OSBPL3 SYNE1 MTERF3 MIPEP SPAG9 RERE SNX19 DDX28 | 8.64e-05 | 1496 | 87 | 13 | 32877691 |
| Pubmed | 9.08e-05 | 568 | 87 | 8 | 9110174 | ||
| Pubmed | 9.22e-05 | 6 | 87 | 2 | 35314700 | ||
| Pubmed | TANGO1 recruits Sec16 to coordinately organize ER exit sites for efficient secretion. | 9.22e-05 | 6 | 87 | 2 | 28442536 | |
| Pubmed | Reactive nitrogen species regulate autophagy through ATM-AMPK-TSC2-mediated suppression of mTORC1. | 9.22e-05 | 6 | 87 | 2 | 23878245 | |
| Pubmed | PAF-Myc-Controlled Cell Stemness Is Required for Intestinal Regeneration and Tumorigenesis. | 9.22e-05 | 6 | 87 | 2 | 29533773 | |
| Pubmed | Ranking novel cancer driving synthetic lethal gene pairs using TCGA data. | 9.22e-05 | 6 | 87 | 2 | 27438146 | |
| Pubmed | 9.22e-05 | 6 | 87 | 2 | 25270258 | ||
| Pubmed | 9.22e-05 | 6 | 87 | 2 | 28842482 | ||
| Pubmed | A "double adaptor" method for improved shotgun library construction. | 9.77e-05 | 574 | 87 | 8 | 8619474 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | EFHC2 POSTN GALC LRFN1 NF1 PITRM1 MTOR OSBPL3 SIPA1L1 AFDN PDE5A SPAG9 | 1.10e-04 | 1321 | 87 | 12 | 27173435 |
| Pubmed | 1.15e-04 | 754 | 87 | 9 | 35906200 | ||
| Pubmed | Targeted proteomic analysis of 14-3-3 sigma, a p53 effector commonly silenced in cancer. | 1.29e-04 | 102 | 87 | 4 | 15778465 | |
| Pubmed | 1.29e-04 | 7 | 87 | 2 | 8982467 | ||
| Pubmed | 1.29e-04 | 7 | 87 | 2 | 16828986 | ||
| Pubmed | 1.29e-04 | 7 | 87 | 2 | 17384681 | ||
| Pubmed | MCM9 deficiency delays primordial germ cell proliferation independent of the ATM pathway. | 1.29e-04 | 7 | 87 | 2 | 26388201 | |
| Pubmed | 1.29e-04 | 7 | 87 | 2 | 16906226 | ||
| Pubmed | Monoubiquitination of H2AX protein regulates DNA damage response signaling. | 1.29e-04 | 7 | 87 | 2 | 21676867 | |
| Pubmed | Affinity switching of the LEDGF/p75 IBD interactome is governed by kinase-dependent phosphorylation. | 1.29e-04 | 7 | 87 | 2 | 29997176 | |
| Pubmed | 1.29e-04 | 7 | 87 | 2 | 29202468 | ||
| Pubmed | 1.29e-04 | 7 | 87 | 2 | 21896734 | ||
| Pubmed | 1.32e-04 | 446 | 87 | 7 | 24255178 | ||
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | PDIA4 NBAS PHF20L1 SYNE1 APC MICAL3 SPAG9 POGZ ATM LTF DDX28 | 1.44e-04 | 1155 | 87 | 11 | 20360068 |
| Pubmed | 1.72e-04 | 8 | 87 | 2 | 29275959 | ||
| Pubmed | Distinct Roles of HES1 in Normal Stem Cells and Tumor Stem-like Cells of the Intestine. | 1.72e-04 | 8 | 87 | 2 | 28536281 | |
| Pubmed | 1.72e-04 | 8 | 87 | 2 | 24239381 | ||
| Pubmed | 1.72e-04 | 8 | 87 | 2 | 20810650 | ||
| Pubmed | 1.72e-04 | 8 | 87 | 2 | 28335007 | ||
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | PDIA4 NCAPD3 SPCS3 MIA3 INTS1 AFDN POGZ LTF RERE VIRMA ITFG1 | 2.05e-04 | 1203 | 87 | 11 | 29180619 |
| Pubmed | 2.20e-04 | 9 | 87 | 2 | 25010009 | ||
| Pubmed | Role of Gadd45a in Wip1-dependent regulation of intestinal tumorigenesis. | 2.20e-04 | 9 | 87 | 2 | 22555459 | |
| Pubmed | 2.20e-04 | 9 | 87 | 2 | 27340174 | ||
| Pubmed | 2.20e-04 | 9 | 87 | 2 | 28628639 | ||
| Pubmed | 2.22e-04 | 486 | 87 | 7 | 20936779 | ||
| Pubmed | 2.28e-04 | 650 | 87 | 8 | 38777146 | ||
| Pubmed | 2.42e-04 | 347 | 87 | 6 | 17114649 | ||
| Pubmed | Tel2 regulates the stability of PI3K-related protein kinases. | 2.75e-04 | 10 | 87 | 2 | 18160036 | |
| Pubmed | 2.88e-04 | 230 | 87 | 5 | 29513927 | ||
| Pubmed | 3.06e-04 | 52 | 87 | 3 | 26499835 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 3.07e-04 | 861 | 87 | 9 | 36931259 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | 3.20e-04 | 1061 | 87 | 10 | 33845483 | |
| Pubmed | 3.27e-04 | 686 | 87 | 8 | 28380382 | ||
| Pubmed | Tti1 and Tel2 are critical factors in mammalian target of rapamycin complex assembly. | 3.35e-04 | 11 | 87 | 2 | 20427287 | |
| Pubmed | 3.35e-04 | 11 | 87 | 2 | 28496133 | ||
| Pubmed | 3.37e-04 | 689 | 87 | 8 | 36543142 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 3.73e-04 | 1082 | 87 | 10 | 38697112 | |
| Pubmed | 3.81e-04 | 56 | 87 | 3 | 37059927 | ||
| Interaction | KCTD3 interactions | 7.03e-06 | 164 | 87 | 7 | int:KCTD3 | |
| Interaction | FAM110B interactions | 1.04e-05 | 67 | 87 | 5 | int:FAM110B | |
| Interaction | STARD13 interactions | 1.12e-05 | 68 | 87 | 5 | int:STARD13 | |
| Interaction | WEE1 interactions | 2.40e-05 | 133 | 87 | 6 | int:WEE1 | |
| Cytoband | 8q23 | 5.33e-04 | 18 | 87 | 2 | 8q23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7p15 | 9.58e-04 | 101 | 87 | 3 | chr7p15 | |
| Cytoband | 11q25 | 1.12e-03 | 26 | 87 | 2 | 11q25 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr11q25 | 1.59e-03 | 31 | 87 | 2 | chr11q25 | |
| Cytoband | 8q22.1 | 2.64e-03 | 40 | 87 | 2 | 8q22.1 | |
| GeneFamily | Fibronectin type III domain containing | 9.18e-04 | 160 | 49 | 4 | 555 | |
| Coexpression | GSE42021_TREG_PLN_VS_CD24LO_TREG_THYMUS_UP | 2.99e-07 | 196 | 87 | 8 | M9578 | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.93e-06 | 189 | 87 | 6 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | COVID-19_Severe-immature_Neutrophil|COVID-19_Severe / Disease condition and Cell class | 2.60e-06 | 199 | 87 | 6 | f82fa9d651e78f9ebbe6264e00a48c54b1786a69 | |
| ToppCell | COVID-19_Severe-immature_Neutrophil-|COVID-19_Severe / Disease condition and Cell class | 2.60e-06 | 199 | 87 | 6 | 42ea0c19c455bdb0ae89b428d09c333104c670dc | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Lymphocytic-Proliferating_NK|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-05 | 171 | 87 | 5 | 1eebd7138c3b20ddc1104f21615f9df0e776bbe6 | |
| ToppCell | PND14-Immune-Immune_Myeloid-DC-cDC1-cDC1_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.34e-05 | 174 | 87 | 5 | 09b091e24317c3f7bac043f04762a533e30793de | |
| ToppCell | facs-Marrow-B-cells-18m-Hematologic-MPP_Fraction_B_+_C|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.75e-05 | 180 | 87 | 5 | 7368ab31c3273374ef260f0d710d4eea83cbc4a2 | |
| ToppCell | CV-Healthy-7|CV / Virus stimulation, Condition and Cluster | 3.05e-05 | 184 | 87 | 5 | 0e5cc77aaa73ceb791f8be7456177577fd2e5586 | |
| ToppCell | droplet-Marrow-nan-21m-Lymphocytic-naive_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-05 | 186 | 87 | 5 | 744bf39af2fb5a7454477174d7755a6d78cd279f | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.30e-05 | 187 | 87 | 5 | 58d48128547ee3513d0bf7f78e61b76b1c472ca9 | |
| ToppCell | droplet-Marrow-nan-18m-Lymphocytic-naive_T_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.38e-05 | 188 | 87 | 5 | 1b349618f77260564486586b7f5a47a77d12859c | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-AT2_Progenitor|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.47e-05 | 189 | 87 | 5 | 5f883ef4cc0383142d538ae61f4fb40dfdb8ef18 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.22e-05 | 197 | 87 | 5 | b94645d57efe8d9e032bffb8c89af1f425c6421e | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.22e-05 | 197 | 87 | 5 | 3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3 | |
| ToppCell | LPS_IL1RA-Epithelial_alveolar-AT_2-Differentiating_AT2|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.33e-05 | 198 | 87 | 5 | 285f729140b1df029c24f6ca1d2438470ac51794 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.33e-05 | 198 | 87 | 5 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS_only / Treatment groups by lineage, cell group, cell type | 4.54e-05 | 200 | 87 | 5 | 2dadf317a42a7e27cc1fac74f91b806c93a57108 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.54e-05 | 200 | 87 | 5 | a4ec0e80f5422b91b85264a9bb74568dd577e285 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-A_(Artery)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.54e-05 | 200 | 87 | 5 | 89eae23195d57f1b23a337ff19c9b8a367e22c96 | |
| ToppCell | Severe-Developping_Plasmablast|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 4.54e-05 | 200 | 87 | 5 | 6d0cd00e52568d23597cc2a4059bd967d7d2dab5 | |
| ToppCell | severe-immature_Neutrophil|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.54e-05 | 200 | 87 | 5 | 5ee43386da8261d2e7602a152e6ba4338d844e08 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-A_(Artery)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 4.54e-05 | 200 | 87 | 5 | fa99901388eec28004bef85d84f0d7d5bd4df4a8 | |
| Disease | Intellectual Disability | 5.77e-06 | 447 | 85 | 9 | C3714756 | |
| Disease | Hematochezia | 4.90e-05 | 4 | 85 | 2 | C0018932 | |
| Disease | Glioblastoma | 8.17e-05 | 79 | 85 | 4 | C0017636 | |
| Disease | unipolar depression, bipolar disorder | 9.04e-05 | 156 | 85 | 5 | EFO_0003761, MONDO_0004985 | |
| Disease | Giant Cell Glioblastoma | 1.04e-04 | 84 | 85 | 4 | C0334588 | |
| Disease | thalamus volume | 1.09e-04 | 85 | 85 | 4 | EFO_0006935 | |
| Disease | Glioma | 1.19e-04 | 87 | 85 | 4 | C0017638 | |
| Disease | obsessive-compulsive disorder, attention deficit hyperactivity disorder, Tourette syndrome, unipolar depression, bipolar disorder, autism spectrum disorder, schizophrenia, anorexia nervosa | 2.88e-04 | 200 | 85 | 5 | EFO_0003756, EFO_0003761, EFO_0003888, EFO_0004242, EFO_0004895, MONDO_0004985, MONDO_0005090, MONDO_0005351 | |
| Disease | Gastrointestinal Hemorrhage | 2.91e-04 | 9 | 85 | 2 | C0017181 | |
| Disease | Glioblastoma Multiforme | 3.04e-04 | 111 | 85 | 4 | C1621958 | |
| Disease | Malignant Neoplasms | 5.21e-04 | 128 | 85 | 4 | C0006826 | |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 8.40e-04 | 15 | 85 | 2 | C0496930 | |
| Disease | Benign neoplasm of bladder | 8.40e-04 | 15 | 85 | 2 | C0154017 | |
| Disease | Carcinoma in situ of bladder | 8.40e-04 | 15 | 85 | 2 | C0154091 | |
| Disease | Colorectal Carcinoma | 9.49e-04 | 702 | 85 | 8 | C0009402 | |
| Disease | Malignant lymphoma, lymphocytic, intermediate differentiation, diffuse | 9.59e-04 | 16 | 85 | 2 | C0334634 | |
| Disease | Benign neoplasm of stomach | 1.08e-03 | 17 | 85 | 2 | C0153943 | |
| Disease | Eye Abnormalities | 1.08e-03 | 17 | 85 | 2 | C0015393 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 1.08e-03 | 17 | 85 | 2 | C0496905 | |
| Disease | Carcinoma in situ of stomach | 1.08e-03 | 17 | 85 | 2 | C0154060 | |
| Disease | Carcinoma of bladder | 1.22e-03 | 18 | 85 | 2 | C0699885 | |
| Disease | Colorectal Neoplasms | 1.25e-03 | 277 | 85 | 5 | C0009404 | |
| Disease | serum albumin measurement | 1.62e-03 | 592 | 85 | 7 | EFO_0004535 | |
| Disease | Stomach Carcinoma | 1.66e-03 | 21 | 85 | 2 | C0699791 | |
| Disease | congestive heart failure (is_marker_for) | 1.73e-03 | 82 | 85 | 3 | DOID:6000 (is_marker_for) | |
| Disease | lymphocyte count, response to vaccine | 1.82e-03 | 22 | 85 | 2 | EFO_0004587, EFO_0004645 | |
| Disease | Immunologic Deficiency Syndromes | 1.99e-03 | 23 | 85 | 2 | C0021051 | |
| Disease | nevus count, cutaneous melanoma | 2.33e-03 | 91 | 85 | 3 | EFO_0000389, EFO_0004632 | |
| Disease | refractive error | 2.55e-03 | 326 | 85 | 5 | MONDO_0004892 | |
| Disease | Hereditary Nonpolyposis Colorectal Neoplasms | 2.55e-03 | 26 | 85 | 2 | C0009405 | |
| Disease | mean fractional anisotropy measurement | 2.64e-03 | 95 | 85 | 3 | EFO_0008399 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EFRESSEDSFLSAII | 606 | P55196 | |
| VILDDSDLFDTDLDF | 1571 | Q96QE3 | |
| IDVDTEFLASFSTEG | 521 | P59827 | |
| LSSFLDEELALDGSF | 811 | Q8NEN0 | |
| DDAEFELTETFNISL | 3991 | Q8WXG9 | |
| LSSEFDITEDFLSTS | 4686 | Q8WXG9 | |
| GLTDEFEELEFLSTI | 36 | P39687 | |
| ESSLTADLLSVDAFA | 606 | O60641 | |
| RSLLDSDDSSDLLDF | 841 | Q5TGY3 | |
| FSLTSELLDSESLTE | 846 | Q9UPM8 | |
| LLAEDSFDESDFSEI | 21 | Q96DM1 | |
| LAFDVTDLESFEALD | 86 | Q96AH8 | |
| ELEECDIFFEESSSL | 406 | Q96RS6 | |
| AFDFLSEETEASLAS | 606 | O60271 | |
| ESTDEFSELSFRISE | 316 | O75427 | |
| TAFDDVFALEELDLS | 141 | Q96NI6 | |
| SDSEFLEFLDLEDAQ | 21 | Q9H790 | |
| ERLAEETLDSLAEFF | 96 | Q16595 | |
| ETLDSLAEFFEDLAD | 101 | Q16595 | |
| LSFSEDSDLSSDDVL | 1791 | Q7RTP6 | |
| LEELLTAFFSATADA | 1556 | Q8N201 | |
| VDDDSLARILSFSDS | 386 | Q96S65 | |
| LSELDEEFDSLYSIL | 76 | Q9BXM9 | |
| DFSAAFEILSREEEA | 2746 | Q8NDA2 | |
| AFDAFLSTVEDLDLS | 156 | Q9P244 | |
| FTLEELDEFTFVDET | 1856 | Q2LD37 | |
| DESLLLFEDVNTEFD | 1131 | Q8IYD8 | |
| LFEDVNTEFDDVSLS | 1136 | Q8IYD8 | |
| EADLDSTSLTSEEVF | 251 | Q5VZ46 | |
| TDDEIISLSIEFFDQ | 126 | P35226 | |
| SDDLLESLLSRFEDS | 671 | Q5JST6 | |
| ITDFSFSDFELSDLE | 556 | O76074 | |
| FSDFELSDLETALCT | 561 | O76074 | |
| DSESLADDFTIQLSD | 1241 | Q5H8C1 | |
| FSLDDSEIEDSLTEA | 21 | Q14D04 | |
| SFLVLDEADTLLDES | 281 | Q9NUL7 | |
| RIFIEDTDSETEDFA | 71 | Q96GN5 | |
| TLSILDENDDFTIDS | 606 | Q9BZA7 | |
| EFLFTDSGLSTLEIE | 1706 | A2RRP1 | |
| FIDFIADEVDLTSAL | 41 | P20839 | |
| TEESLSEDVFTESEL | 331 | Q8N573 | |
| LLVSTDREDFFAVSD | 491 | Q86VX9 | |
| TSAAATSELEEILDF | 486 | B2RXH4 | |
| EELSFSEVEELFLQT | 641 | Q13315 | |
| SFTSSDDIAEVLFLE | 2126 | O75417 | |
| AEELDEAVFLTSFEE | 3646 | Q8N3K9 | |
| SFGSEDSLEFLLDDE | 311 | Q502W7 | |
| QDFESDTFFSEIDLE | 141 | Q86XF0 | |
| DDFLTSDEEVDSVLF | 46 | Q14527 | |
| DGSFTLSLHEDELFT | 451 | P54803 | |
| REEDSFDSDSTATLL | 131 | Q8N137 | |
| VSDSLLFDTSDDEEL | 126 | Q9UHY8 | |
| DSLSEFFDAQEVLLS | 446 | Q9H4L5 | |
| ISSFDSELFLEELDE | 101 | Q96E29 | |
| VDFLDDSSTESLLLS | 641 | A8MW92 | |
| ADSLDFFTDTLTTID | 356 | O43364 | |
| LETVDRLTESLDFTD | 1136 | P42345 | |
| AFIRESTVFEDLSDE | 226 | P02788 | |
| FLSFSSLESLSSELE | 1366 | Q8NF91 | |
| ETTRLVTSLEDDFDE | 291 | Q5JRA6 | |
| VLLFFEETIDSLDED | 61 | Q86WR7 | |
| DEISLFLDTEVLSSD | 1126 | Q7Z3K3 | |
| DITDTFEAFTLSLLS | 336 | Q5JRX3 | |
| SDLGFITFDITADLE | 61 | P61009 | |
| SDITISELDVDSFDE | 176 | O43166 | |
| LSSVFRSFSDEEELT | 526 | Q8TE82 | |
| SVLSSDSFDLLDLQE | 576 | O60285 | |
| EEFDSDTLREFVTAF | 491 | P13667 | |
| EFLDLSSASEDDFDS | 481 | Q9P2R6 | |
| VEFLTSSDTDFLLED | 171 | Q9UJM3 | |
| LESFDFLNTSDFDEE | 661 | Q9Y4F9 | |
| GSFETTADDIIDSLF | 96 | Q01718 | |
| SLSSLDFDDDDVDLS | 1861 | P25054 | |
| LSFEDFLDLLSVFSD | 86 | Q99828 | |
| LDASELLSDTFEVLS | 1136 | P42695 | |
| IEEEDFLDSFTSLEQ | 431 | Q9UJT1 | |
| LTNSEESLDFSESLE | 76 | O95398 | |
| DDFVSALVSDLDLDF | 691 | Q99797 | |
| EDGDLITIFDSSDLS | 61 | Q92734 | |
| DFSEFLSLLGDIATD | 71 | P31151 | |
| TEFDTLAETVLADRF | 1191 | P21359 | |
| TFRTLSDLIFDFEDS | 221 | Q86V25 | |
| EFLDLSASVEESAAT | 961 | Q92543 | |
| SFSEEDLFIEIAGLS | 171 | Q96BW9 | |
| FFSLLSDIISSEDEE | 106 | Q13061 | |
| DLTEDFTADLFLTTL | 211 | Q8TB96 | |
| SIQDFIEAEDDLSSF | 236 | Q15063 | |
| TFSTNASLEIFELDL | 36 | O94979 | |
| AESDLSSVTDEVFLE | 181 | A5PLN9 | |
| SDFDLHSELERSFLS | 1561 | Q69YN4 | |
| EEEDSLDLSSTFVSL | 226 | Q49AM3 | |
| DQEELFTSISEIFSD | 46 | Q86UW6 |